The levels of immune reactivity of peripheral and blood T-lymphocytes were evaluated in 37 bladder cancer patients and 31 age-matched controls. T-lymphocyte subsets were quantified by monoclonal antibodies, and the immune reactivity was measured using stimulation with phytohemagglutinin (PHA), concanavalin A (ConA), and pokeweed mitogen (PWM). Comparing the patients before and after treatment revealed significant changes in the stimulation index of proliferative response to PHA, PWM, in the PWM% (the patient response compared to the control), and in the percent of T8 cells from the total count of blood lymphocytes. Further significant differences were found among the disease stages in the numbers of T3, T4 lymphocytes subpopulations and the total lymphocyte count. A significant interaction was found between the treatment and patient's sex regarding the T4:T8 ratio.Also, a higher prevalence of T4:T8<1 was found among the patients compared to the controls before and after treatment regardless of the disease stage. This T4:T8<1 ratio can serve as an indicator of immune competence in bladder transitional cell carcinoma patients.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Brosman S, Elhilali M, Vescera C, Fahey JF (1979) Immune response in bladder cancer patients. J Urol 121:162
Bubenik J, Perlmann P, Helmstein K, Moberger G (1970) Immune response to urinary tumors in man. Int J Cancer 5:39
Handzel ZT, Berner Y, Segal O, Burstein Y, Buchner V, Pecht M, Levin S, Burstein R, Milchan R, Bentwich Z, Ben-Ishai Z, Trainin N (1987) Immunoreconstitution of T-cell impairments in asymptomatic male homosexuals by thymic humoral factor (THF). Int J Immunopharmacol 9:165
Harris JE, DeBoer KP, Vahey AL, Braum DP (1982) The measurement of leukocyte subsets in the peripheral blood of cancer patients with solid tumors using monoclonal antibody reagents. Med Pediatr Oncol 10:185
Laor E, Schiffman Z, Reid RE, Tolia BM, Freed SZ (1984) Sex dependent variation in natural history of transitional cell carcinoma of the bladder. Urology 23:237
Laurence J (1985) The immune system in AIDS. Sci Am 253:70
Morales A, Eidinger D, Bruce AW (1976) Intracavitary bacillus Calmett-Guerin in the treatment of superficial bladder tumors. J Urol 116:180
Nishio S, Horii A, Morikawa Y, Kawakita J, Nishijima T, Kishimoto T, Maekawa M (1979) Studies of nonspecific cellular immune response in patients with urinary bladder carcinoma. 1. PHA induced lymphocyte transfromation. Invest Urol 16:336
Nordman E, Lehto I, Toivanen A (1985) Immune functions and the prognosis of patients with solid tumours. Cancer Immunol Immunother 20:38
O'Tool C, Perlmann P, Unsgaard B, Moberger G, Edsmyr F (1972) Cellular immunity to human urinary bladder carcinoma. 1. Correlation to clinical stage and radiotherapy. Int J Cancer 10:77
O'Tool C, Perlmann P, Unsgaard B, Almgard LE, Johansson B, Moberger G, Edsmyr F (1972) Cellular immunity to human urinary bladder carcinoma. 2. Effect of surgery and preoperative irradiation. Int J Cancer 10:92
Reinherz EL, Kung PC, Goldstein G, Schlossman SF (1979) A monoclonal antibody with selectivity with functionally mature human thymocytes and all peripheral human T cells. J Immunol 123:1312
Shaw M, Ray P, Rubenstein M, Guinan P (1987) Lymphocyte subsets in urologic cancer patients. Urol Res 15:181
About this article
Cite this article
Greenstein, A., Pecht, M., Kaver, I. et al. Characterization of peripheral blood T-cell subpopulation of bladder cancer patients. Urol. Res. 19, 219–222 (1991). https://doi.org/10.1007/BF00305298
- Bladder cancer
- Peripheral blood T-lymphocytes
- Immune response